Company profile RPHM
After 39 days of this quarter the interest is at 36.0. Based on that we can calculate that during remaining 52 days it will total up to 84.0. Reneo Pharmaceuticals expected interest is significantly lower compared to previous quarter (-65.4%) and same quarter last year (-40.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 40 | 187 367.5% QoQ | 35 -81.3% QoQ | 95 171.4% QoQ |
| 2020 | 79 97.5% YoY -16.8% QoQ | 86 -54.0% YoY 8.9% QoQ | 59 68.6% YoY -31.4% QoQ | 79 -16.8% YoY 33.9% QoQ |
| 2021 | 63 -20.3% YoY -20.3% QoQ | 225 161.6% YoY 257.1% QoQ | 128 116.9% YoY -43.1% QoQ | 126 59.5% YoY -1.6% QoQ |
| 2022 | 30 -52.4% YoY -76.2% QoQ | 113 -49.8% YoY 276.7% QoQ | 57 -55.5% YoY -49.6% QoQ | 114 -9.5% YoY 100.0% QoQ |
| 2023 | 140 366.7% YoY 22.8% QoQ | 122 8.0% YoY -12.9% QoQ | 201 252.6% YoY 64.8% QoQ | 243 113.2% YoY 20.9% QoQ |
| 2024 | 36 -74.3% YoY -85.2% QoQ | - | - | - |
The average 5 years interest of Reneo Pharmaceuticals was 8.65 per week. The last year interest of Reneo Pharmaceuticals compared to the last 5 years has changed by 50.98%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 78.17%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Reneo Pharmaceuticals stock expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 31 | 92 196.8% QoQ | 237 157.6% QoQ | 89 -62.4% QoQ |
| 2020 | 61 96.8% YoY -31.5% QoQ | 28 -69.6% YoY -54.1% QoQ | 64 -73.0% YoY 128.6% QoQ | 131 47.2% YoY 104.7% QoQ |
| 2021 | 131 114.8% YoY 0.0% QoQ | 120 328.6% YoY -8.4% QoQ | 83 29.7% YoY -30.8% QoQ | 118 -9.9% YoY 42.2% QoQ |
| 2022 | 196 49.6% YoY 66.1% QoQ | 83 -30.8% YoY -57.7% QoQ | 54 -34.9% YoY -34.9% QoQ | 57 -51.7% YoY 5.6% QoQ |
| 2023 | 37 -81.1% YoY -35.1% QoQ | 66 -20.5% YoY 78.4% QoQ | 267 394.4% YoY 304.5% QoQ | 220 286.0% YoY -17.6% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Reneo Pharmaceuticals stock was 8.3 per week. The last year interest of Reneo Pharmaceuticals stock compared to the last 5 years has changed by 36.75%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 15.7%.
There is not enough data for REN001 to provide analysis
There is not enough data for REN001 to provide correlation calculation
There is not enough data for REN001 to provide analysis
There is not enough data for peroxisome proliferator-activated receptor delta to provide analysis
There is not enough data for peroxisome proliferator-activated receptor delta to provide correlation calculation
There is not enough data for peroxisome proliferator-activated receptor delta to provide analysis
There is not enough data for primary mitochondrial myopathies to provide analysis
There is not enough data for primary mitochondrial myopathies to provide correlation calculation
There is not enough data for primary mitochondrial myopathies to provide analysis
There is not enough data for long-chain fatty acid oxidation disorders to provide analysis
There is not enough data for long-chain fatty acid oxidation disorders to provide correlation calculation
There is not enough data for long-chain fatty acid oxidation disorders to provide analysis
There is not enough data for rare genetic mitochondrial diseases to provide analysis
There is not enough data for rare genetic mitochondrial diseases to provide correlation calculation
There is not enough data for rare genetic mitochondrial diseases to provide analysis
There is not enough data for Reneo Pharmaceuticals address to provide analysis
There is not enough data for Reneo Pharmaceuticals address to provide correlation calculation
There is not enough data for Reneo Pharmaceuticals address to provide analysis
There is not enough data for Reneo Pharmaceuticals contact to provide analysis
There is not enough data for Reneo Pharmaceuticals contact to provide correlation calculation
There is not enough data for Reneo Pharmaceuticals contact to provide analysis
After 39 days of this quarter the interest is at 255.0. Based on that we can calculate that during remaining 52 days it will total up to 595.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 541 | 733 35.5% QoQ | 739 0.8% QoQ | 954 29.1% QoQ |
| 2020 | 718 32.7% YoY -24.7% QoQ | 796 8.6% YoY 10.9% QoQ | 765 3.5% YoY -3.9% QoQ | 903 -5.3% YoY 18.0% QoQ |
| 2021 | 724 0.8% YoY -19.8% QoQ | 665 -16.5% YoY -8.1% QoQ | 736 -3.8% YoY 10.7% QoQ | 915 1.3% YoY 24.3% QoQ |
| 2022 | 781 7.9% YoY -14.6% QoQ | 790 18.8% YoY 1.2% QoQ | 768 4.3% YoY -2.8% QoQ | 791 -13.6% YoY 3.0% QoQ |
| 2023 | 654 -16.3% YoY -17.3% QoQ | 640 -19.0% YoY -2.1% QoQ | 618 -19.5% YoY -3.4% QoQ | 775 -2.0% YoY 25.4% QoQ |
| 2024 | 255 -61.0% YoY -67.1% QoQ | - | - | - |
The average 5 years interest of Michael Grey was 58.47 per week. The last year interest of Michael Grey compared to the last 5 years has changed by -12.91%. The interest for Michael Grey is seasonal. The last year interest is quite lower compared to 5 years ago. It has decreased by -19.07%.